Figure 7. Association of risk score and immune infiltration landscape in CM. (A–D) Stromal, immune, ESTIMATE scores, and tumor purity. (E) TIDE score. (F–H) IPS score. (I) The proportion of 23-type immune cells of patients in the low- and high-risk group. (J) Immune function score. (K) Expression of immune checkpoints inhibitor (ICI) of in low- and high-risk group. The expression of ICI was transformed by log2 (expression + 1). (L) Correlation analysis of 5 prognostic HRLs and 23-type immune cells.